White House reverses decision to suspend ads promoting ACA insurance enrollment

White House officials shared plans Thursday to withdraw ads encouraging Americans to sign up for health insurance through HealthCare.gov in the final days before the open enrollment period for 2017 coverage closes, then reversed that decision Friday afternoon.

Advertisement

[Update] As of 5 p.m. CST Friday, Politico reported the Trump administration reversed its decision to stop outreach regarding health insurance enrollment under the ACA exchanges. HHS officials on Friday said automatic phone calls and other online and digital outreach — including Twitter messages and emails — would continue through the Jan. 31 deadline for obtaining coverage.

Early Friday, Politico reported that HHS officials said ads that had already been paid for and placed were being withdrawn ahead of the Jan. 31 deadline. In addition, media outreach about signing up and emails distributed to those with incomplete applications have been suspended, according to the report.

An HHS spokesperson said Thursday the “federal government has spent more than $60 million promoting the open enrollment period. We have pulled back roughly $5 million of the final placement in an effort to look for efficiencies where they exist,” according to NYT.

In the last few years, the final days of open enrollment have been coupled with a large number of last-minute enrollees, according to the report.   

 

More articles on payer issues:

Connecticut health insurance exchange calls for mandatory broker commissions
9 ways ACA repeal could affect employer-sponsored insurance
Audit: Highmark received $96k in overpayments from Pennsylvania county

Advertisement

Next Up in Uncategorized

  • Health systems are navigating a rapidly evolving healthcare environment where patient safety is shaped by both longstanding challenges and emerging…

  • Since 2020, CHS has announced or completed the sale of 35 hospitals:  2025 2024 2023 2022 2021 In July 2021,…

  • Sacroiliac joint fusion technology is advancing, and the data shows it’s efficacy across different medtech companies. Five notes: 1. Tenon…

Advertisement

Comments are closed.